Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

583 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot.
Alexander JH, Dyke CK, Yang H, Becker RC, Hasselblad V, Zillman LA, Kleiman NS, Hochman JS, Berger PB, Cohen EA, Lincoff AM, Saint-Jacques H, Chetcuti S, Burton JR, Buergler JM, Spence FP, Shimoto Y, Robertson TL, Kunitada S, Bovill EG, Armstrong PW, Harrington RA; XaNADU-PCI PILOT Investigators. Alexander JH, et al. Among authors: becker rc. J Thromb Haemost. 2004 Feb;2(2):234-41. doi: 10.1111/j.1538-7933.2004.00594.x. J Thromb Haemost. 2004. PMID: 14995984 Free article. Clinical Trial.
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial.
Alexander JH, Yang H, Becker RC, Kodama K, Goodman S, Dyke CK, Kleiman NS, Hochman JS, Berger PB, Cohen EA, Lincoff AM, Burton JR, Bovill EG, Kawai C, Armstrong PW, Harrington RA; XaNADU-ACS INVESTIGATORS. Alexander JH, et al. Among authors: becker rc. J Thromb Haemost. 2005 Mar;3(3):439-47. doi: 10.1111/j.1538-7836.2004.01081.x. J Thromb Haemost. 2005. PMID: 15748230 Free article. Clinical Trial.
Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee.
Ohman EM, Granger CB, Rice L, Abrams CS, Becker RC, Berger PB, Kleiman NS, Moliterno D, Moll S, Rodgers JE, Steinhubl SS, Tapson VF, Sinnaeve P, Anstrom KJ; Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry. Ohman EM, et al. Among authors: becker rc. J Thromb Thrombolysis. 2005 Feb;19(1):11-9. doi: 10.1007/s11239-005-0850-7. J Thromb Thrombolysis. 2005. PMID: 15976962
Antithrombotic therapy practices in US hospitals in an era of practice guidelines.
Tapson VF, Hyers TM, Waldo AL, Ballard DJ, Becker RC, Caprini JA, Khetan R, Wittkowsky AK, Colgan KJ, Shillington AC; NABOR (National Anticoagulation Benchmark and Outcomes Report) Steering Committee. Tapson VF, et al. Among authors: becker rc. Arch Intern Med. 2005 Jul 11;165(13):1458-64. doi: 10.1001/archinte.165.13.1458. Arch Intern Med. 2005. PMID: 16009860 Clinical Trial.
Platelet function monitoring in patients with coronary artery disease.
Gurbel PA, Becker RC, Mann KG, Steinhubl SR, Michelson AD. Gurbel PA, et al. Among authors: becker rc. J Am Coll Cardiol. 2007 Nov 6;50(19):1822-34. doi: 10.1016/j.jacc.2007.07.051. Epub 2007 Oct 23. J Am Coll Cardiol. 2007. PMID: 17980247 Free article. Review.
Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy.
Oliveira GB, Crespo EM, Becker RC, Honeycutt EF, Abrams CS, Anstrom KJ, Berger PB, Davidson-Ray LD, Eisenstein EL, Kleiman NS, Moliterno DJ, Moll S, Rice L, Rodgers JE, Steinhubl SR, Tapson VF, Ohman EM, Granger CB; Complications After Thrombocytopenia Caused by Heparin (CATCH) Registry Investigators. Oliveira GB, et al. Among authors: becker rc. Arch Intern Med. 2008 Jan 14;168(1):94-102. doi: 10.1001/archinternmed.2007.65. Arch Intern Med. 2008. PMID: 18195201
583 results